Podcasts about canadian task force

The Canadian Task Force on Preventive Health caused a stir recently, when it put out new breast cancer screening guidelines. The guidelines recommend against screening for women in their 40s, among other things. That has confused, and upset some people. Our health care columnist Mary Jane Hampton looks at that in this week's column.

CBC House Doctor Raj Bhardwaj says the Canadian Task Force on Preventative Health Care is under some scrutiny for updates to its recommendations on when to start screening.

THE ZOOMER SQUAD: CARP CALLS ON BC GOVERNMENT FOR FREE RSV, SHINGLES VACCINES FOR ZOOMERS Libby Znaimer is joined by Anthony Quinn, Chief Community Officer of CARP, Rudy Buttignol, President of CARP and John Wright, Executive Vice President of Maru Public Opinion. It's Monday - time for our Zoomer Squad and CARP is getting some traction on its campaign demanding government coverage for vaccines crucial to the health of older Canadians - like the RSV vaccine. The need to pay for those and for so much else is driving Zoomers back to work out of necessity rather than desire. And former Bank of Canada Governor Stephen Poloz is looking into how the CPP and other pension funds can invest more here in Canada. Is that a good or bad idea? NEW GUIDELINES FOR BREAST CANCER SCREENING Libby Znaimer is now joined by Dr. Martin Yaffe, Senior Scientist at Sunnybrook Research Institute and Co-Director, Imaging Research Program at the Ontario Institute for Cancer Research as well as Siobhan Grennan, who was part of the Working Group for these updated guidelines for Breast Cancer Screening from the Canadian Task Force on Preventive Health. What is the right age to start screening women of average risk for breast cancer? That question has become the subject of controversy. In the US, the age was lowered from 50 to 40 and the CCS and quite a number of specialists recommended that we do the same here. However, the Canadian Task Force on Preventative Health Care, a group created by the federal government, has not lowered the recommended guideline. It cites the possible harms from both false positives and false negatives, among other reasons. And the current guideline to stop screening is 74. Given that women are living longer, is that just ageist? UOFT PROFESSOR SAYS DEMANDS FOR A UNIVERSITY DIVESTMENT OF ISRAELI COMPANIES IS IMPOSSIBLE AND IMMORAL Libby Znaimer is now joined by Rami Elitzur , a professor at the Rotman School of Management who is also a serving member on the University of Toronto Governing Council. One of the key demands by the anti-Israel encampment on the UofT campus is for the university to divest from Israeli companies. But as Professor Elitzur explains, so many of the important technologies we rely on in our daily lives, including in high-tech and healthcare, have ties to Israeli companies.

For years, medical experts have been calling for the national guideline for routine breast cancer screenings to be lowered from 50-years-old. But last week, the Canadian Task Force on Preventive Health Care released a draft recommendation that said it's not going to lower the recommended screening age to 40 for women with average risk – and that decision has been met with widespread disapproval. Our AMA guest this week was Dr. Jean Seely. She's the head of the breast imaging section at the Ottawa Hospital and professor of medicine in the radiology department at the University of Ottawa. Dr. Seely answered your questions about screening for breast cancer.

The Canadian Task Force on Preventive Health issued its new screening guidelines for breast cancer on Thursday. Some cancer survivors, screening advocates, and experts are disappointed. A breast radiologist and breast cancer survivor weigh in.

THE MEDICAL RECORD: CANCER SCREENING GUIDELINES  Libby Znaimer today is joined by Dr. Malcolm Moore, Medical Oncologist, Princess Margaret Cancer Centre, Dr. Fahad Razak, Canada Research Chair in Data Informed Healthcare Improvement at the University of Toronto, and Dr. Alisa Naiman, Family Physician and Founder and Medical Director of The Medical Station in Toronto. It's Wednesday, time to talk about your health. We'll begin with the latest cancer screening controversy: a federally appointed body called The Canadian Task Force on Preventive Health issues the guidelines that another group of medical experts are now calling dangerous and outdated.   REACTION TO THE FEDERAL BUDGET RELEASED IN OTTAWA THIS WEEK Libby Znaimer today is joined by Taylor Scollon, Co-Founder of The Peak, Muhammad Ali, Liberal Strategist and Senior Consultant at Crestview Strategy in Ottawa, John Mykytyshyn, Conservative Activist, Political Consultant and President of Bradgate Research Group. Canadian Deputy Prime Minister and Finance Minister Chrystia Freeland released the federal budget this week. The budget is largely aimed at Gen Zs and Millennials as they face an affordability crisis. The budget also includes a disability benefit program that will see $6.1 billion in funding but payouts won't start until July 2025. THE LATEST ON DONALD TRUMP'S LEGAL TROUBLES  Libby Znaimer today is joined by Dr. Chris Cooper, a Political Science Professor at Western Carolina University.  Donald Trump continues to make headlines for his legal troubles…he is currently facing the hush money trial. The question is: will this complicate his political campaign?   

Women are advocating for regular breast cancer screening to begin at age 40, pushing back against the Canadian Task Force on Preventive Health Care guidelines that recommend starting at age 50. They're fighting for their voices to be heard, as the taskforce reviews its guidelines.

Series 8 | Episode 1: Infectious Diseases in the NICU - RSV GUEST:Joanne M. Langley, MD, MSc, FRCPCProfessor of Pediatrics and Community Health and EpidemiologyGSK-CIHR Chair in Pediatric Vaccinology, Dalhousie UniversityHead, Division of Pediatric Infectious Diseases, IWK HealthHalifax, Nova ScotiaBiography: Dr. Langley is a pediatric infectious disease physician at the IWK Health Centre in Halifax, a professor in the Faculty of Medicine at Dalhousie University, and Director of the Evaluation Group at the Canadian Center for Vaccinology. She conducts studies on the prevention of infectious diseases using vaccines, from phase 1 (first in humans) through to efficacy trials (phase 3) and post-marketing studies of how well vaccines work when they are used in immunization programs (phase 4). These studies are done with collaborators in public health, industry, universities, and non-governmental organizations. Dr. Langley has a particular interest in prevention of respiratory infections such as Respiratory Syncytial Virus and influenza. Her work also focuses on vaccine policy and evidence-based decision making in immunization programs. She is a member of the COVID-19 Science Expert Panel, the Expert Group on Health Systems of the Chief Science Advisor of Canada, a former member of the Canadian Task Force on Preventive Health Care and Canada's National Advisory Committee on Immunization (Chair, 2007-2011), and serves as an advisor on several immunization decision making expert groups. She is an active investigator in the Canadian Immunization Research Network and leads its Clinical Trials Network (CTN). This podcast is sponsored by Sanofi

Providing preventive care can be time consuming, and potential benefits have to be weighed against risks and costs. Dr Nick Pimlott interviews Drs Roland Grad, Donna Reynolds, and Guylène Thériault about their work on a new guideline on screening for fragility fractures and how the concept of “time needed to treat” is gaining importance in guideline development. Read their Prevention in Practice review article in the August 2023 issue of Canadian Family Physician in English (https://www.cfp.ca/content/69/8/537) or French (https://www.cfp.ca/content/69/8/e165). Access the Canadian Task Force on Preventive Health Care's Fragility Fracture Decision Aid at: https://frax.canadiantaskforce.ca/.

Fragility fractures are a major health concern for older adults and can result in disability, admission to hospital and long-term care, and reduced quality of life. The Canadian Task Force on Preventive Health Care guideline published in CMAJ provides evidence-based recommendations on screening for primary prevention of fragility fractures.In this special episode of the CMAJ podcast, CMAJ editor-in-chief Dr. Kirsten Patrick speaks to Dr. Roland Grad, a family physician and an author of the new guideline, about the evidence reviews conducted by the task force, the main points of the new guideline, and how family doctors can use it in practice. The guideline recommends screening females over 65 using the FRAX tool without bone mineral density (BMD) as a risk assessment first strategy. Dr. Grad emphasizes the importance of shared decision making, which can be facilitated using the Fragility Fracture Decision Aid, which incorporates the FRAX tool. This online, interactive tool helps  guide discussions with patients about their fracture risk and potential benefits of preventive treatment.Links to resources mentioned in the interview:Canadian Task Force on Preventive Healthcare guidelineFragility Fractures Clinician InfographicFragility Fracture Decision Aid Article in Journal of Systematic ReviewsJoin us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on Twitter @BlairBigham and @DrmojolaomoleCMAJTwitter (in English): @CMAJ Twitter (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Today's guests: Sarah Kendzior, New York Times bestselling author of Hiding in Plain Sight and The View from Flyover Country / Her latest book is "They Knew: How a Culture of Conspiracy Keeps America Complacent" Dr. Eddy Lang, member - Canadian Task Force on Preventive Health Care / department head for emergency medicine at the University of Calgary's Cumming School of Medicine Cody Battershill, Founder and chief spokesperson - Canada Action

The short answer to this question, according to a new guideline published in CMAJ, is “No.”In this special episode, CMAJ editor in chief, Dr. Kirsten Patrick, talks to Dr. Eddy Lang, lead author of the guideline entitled Recommendation on instrument-based screening for depression during pregnancy and the postpartum period produced by the Canadian Task Force on Preventive Health Care. They discuss why there's not enough evidence to support a recommendation to screen routinely, why that doesn't mean that depression in pregnancy and the postpartum period is not important to diagnose, and in what circumstances use of a screening instrument might be helpful.Blair and Jola will be back next episode.

Dr. Ainsley Moore discusses a new guideline by the Canadian Task Force on Preventive Health Care. The guideline recommends opportunistic screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk. Ainsley unpacks the recommendation and talks about what it means for clinical practice. Dr. Ainsley Moore is a family physician and an associate clinical professor in medicine at McMaster University. She is one of the authors of the CTFPHC guideline published in CMAJ: www.cmaj.ca/lookup/doi/10.1503/cmaj.201967 ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

Public health screening programs are some of the most effective ways of decreasing the development of certain conditions, and cervical cancer screening is no exception. But what isn’t well agreed upon is WHEN women should start being screened for cervical cancer, with major interest groups supporting a strategy that is different than most public health campaigns.  Why does this matter? Not only are thousands of pap tests completed a year that might not be helpful, but women who are diagnosed with cervical dysplasia can be recommended for more invasive testing and procedures that can increase the risk of fertility-related complications.  Listen to this episode to hear what the Canadian Task Force on Preventive Health Care, the Canadian Medical Association Journal, and others think about the current screening practices.  Additional material can be found here:  https://canadiantaskforce.ca/guidelines/published-guidelines/cervical-cancer/ https://www.cmaj.ca/content/191/1/E1 If you enjoyed the episode, be sure to subscribe and leave a 5-star review.   

Dr. Scott Klarenbach shares the key messages out of a new clinical practice guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease. Dr. Klarenbach is a professor in the Department of Medicine, and Assistant Dean, Health Outcomes at the University of Alberta. He is currently Chair of the Alberta Expert Committee on Drug Evaluation and Therapeutics and member of the Canadian Task Force on Preventative Health Care. The guideline is published in CMAJ: www.cmaj.ca/lookup/doi/10.1503/cmaj.190814 ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

Join us as we explore how proper breast care and mammography is important for continued overall health throughout life. Learn more about what breast pain, nipple discharge, and other breast changes mean and discover what to expect with your first mammogram. Featuring special guest Dr. Kelly, an Edmonton family practitioner with the Opioid Dependency Program and former Breast Expert for the Comprehensive Breast Care Program in Edmonton.  Resources:  1) Government of Canada (Information on Mammography):  https://www.canada.ca/en/health-canada/services/health-risks-safety/radiation/medical/mammography.html  2) Canadian Task Force on Preventive Health Care (Guidelines on Breast Cancer Screening): https://canadiantaskforce.ca/guidelines/published-guidelines/breast-cancer-update/ 3) Canadian Cancer Society (Information on Mammography): https://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/tests-and-procedures/mammography/?region=on 4) Alberta Health Services (Comprehensive Breast Care Program): https://www.albertahealthservices.ca/findhealth/service.aspx?Id=1022658 Summary Sheet: BreastCareandMammographySummarySheet.html  

In this interview, Dr. Richard Birtwhistle discusses the recommendations in the clinical practice guideline on screening asymptomatic adults for thyroid dysfunction. The guideline comes from the Canadian Task Force on Preventive Health Care and is published in CMAJ. Dr. Birtwhistle is a family physician, clinical epidemiologist, and emeritus professor of family medicine and public health sciences at Queen’s University. He is also chair of the working group for screening for thyroid dysfunction and previous vice chair of the Canadian Task Force or Preventive Health Care. To read the clinical practice guideline published in CMAJ: www.cmaj.ca/lookup/doi/10.1503/cmaj.190395 ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

Dr. Nick Pimlott interviews Dr. Roland Grad, a family physician and an Associate Professor in the Department of Family Medicine at McGill University in Montreal. He is also a member of the Canadian Task Force on Preventive Health Care. Dr. Grad is the lead author of an article in the August issue of CFP from the Prevention in Practice series entitled, “Age to Stop  - Appropriate Screening in Older Patients”.  Read the full article here: https://www.cfp.ca/content/65/8/543 Read Dr. Grad’s blog that was mentioned in the interview, “Family Medicine and The Canadian Task Force on Preventive Health Care: Are we up for the challenge?” https://www.cfp.ca/news/2019/09/10/09-10  

In this podcast, Dr. Ainsley Moore discusses the latest evidence on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer. The guideline is published in the Canadian Medical Association Journal. Dr. Ainsley Moore is a family physician and Associate Clinical Professor at McMaster University in Hamilton, Ontario. She is vice chair of the Canadian Task Force on Preventive Health Care, the group that authored the guideline. Full guideline article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.180463 ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

El episodio de esta semana lo dedicamos a comentar ciertas controversias y recomendaciones sobre el tratamiento de infecciones urinarias.    Referencias: Ainsley Moore y colaboradores. Canadian Task Force on Preventive Health Care Recommendations on screening for asymptomatic bacteriuria in pregnancy. CMAJ 2018 July 9;190:E823-30. doi: 10.1503/cmaj.171325. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Cai et al . Clin Infect Dis 2012: 55: 772-777.  .Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infection. Cai et al. Clin Infect Dis 2015; 61: 1655-1661. Krumpe PE, Cohn S, Garreltes J, et al. Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. J Antimicrob Chemother. 1999;43(suppl A):117-128. Sandberg T, Skoog G, Hermansson AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012;380(9840):484-490. doi: 10.1016/S0140-6736(12)60608-4. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA. 2000;283(12):1583-1590. Kutob LF, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016;48(5):498-503. doi: 10.1016/j.ijantimicag.2016.07.013. Mercuro NJ, Stogsdill P, Wungwattana M. Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus beta-lactams. Int J Antimicrob Agents. 2018;51(5):687-692. doi: 10.1016/j.ijantimicag.2017.12.007.  Rieger KL, Bosso JA, MacVane SH, Temple Z, Wahlquist A, Bohm N. Intravenous-only or intravenous transitioned to oral antimicrobials for Enterobacteriaceae-associated bacteremic urinary tract infection. Pharmacotherapy. 2017;37(11):1479-1483. doi: 10.1002/phar.2024. Nelson AN, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017;45(5):613-620. doi: 10.1007/s15010-017-1020-5.     La Frase de la Semana: Esta semana la tomamos del escrito español Chufo Llorens. Y la frase dice: La distancia es al amor lo que el viento al fuego: apaga el pequeño, pero aviva el grande.  

In this podcast, Dr. Ainsley Moore discusses a clinical practice guideline on behalf of the Canadian Task Force on Preventive Health Care. This guideline, published in the Canadian Medical Association Journal, reexamines the evidence behind a routine part of prenatal care: screening for asymptomatic bacteriuria in pregnancy. Dr. Ainsley Moore is a family physician and Associate Clinical Professor at McMaster University in Hamilton, Ontario. Full guideline article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.171325 ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

In this podcast, Dr. Brenda Wilson discusses the new guideline on screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings. The guideline is authored by the Canadian Task Force on Preventive Health Care and is published in the Canadian Medical Association Journal. Dr. Brenda Wilson is a professor of Community Health and Humanities at Memorial University of Newfoundland and a member of the Canadian Task Force on Preventive Health Care. Full guideline article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.171430 ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

In this interview, Dr. Harminder Singh takes listeners through the new Canadian Task Force on Preventive Health Care (CTFPHC) guideline on screening for abdominal aortic aneurysm, or AAA. He explains each of the recommendations and the evidence behind them. Dr. Harminder Singh is associate professor of medicine in the departments of Internal Medicine and Community Health Sciences at the University of Manitoba. Dr. Singh is also a member of the CTFPHC and has co-authored the AAA guideline published in CMAJ.  Full guideline article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.170118 ----------------------------------- Subscribe to CMAJ Podcasts on iTunes, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on www.cmaj.ca and on www.cmajblogs.com.

The Canadian Task Force on Preventive Health Care has reviewed the latest literature evidence and published a guideline in the CMAJ on screening for hepatitis C virus (HCV) in adults. Dr. Roland Grad, task force member, practicing family physician and associate professor in the Faculty of Medicine at McGill University, explains the task force’s recommendations on screening for HCV. Full article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.161521

Interview with Dr. Brett Thombs, professor in the Faculty of Medicine at McGill University and senior investigator of the Lady Davis Institute, Jewish General Hospital in Montreal. He is also chair-elect of the Canadian Task Force on Preventive Health Care and chair of the tobacco guideline working group. In their guideline published in the CMAJ, Dr. Thombs and the Task Force reviewed the evidence supporting behavioural interventions for prevention and treatment of smoking in children and youth. He explains their findings in this podcast. Full guideline article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.161242 ----------------------------------- Subscribe to CMAJ Podcasts on iTunes, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on www.cmaj.ca and on www.cmajblogs.com.

Co-host: Dr. Mike Kirlew Links from this week's talk: CFP: "Update on age-appropriate preventive measures and screening for Canadian primary care providers" Canadian Task Force on Preventative Health Care (CTFPHC) guidelines U.S. Preventative Services Task Force (USPSTF) guidelines

This guideline by the Canadian Task Force on Preventive Health Care presents evidence-based recommendations for primary care providers on screening for developmental delay in children aged one to four years with no apparent signs of such delay in primary care settings. The guideline does not offer recommendations for surveillance, case finding or diagnosis of developmental delay. Dr. Patricia Parkin is a pediatrician at the Hospital for Sick Children, and professor in the Department of Pediatrics at the University of Toronto. She co-authored the guideline, published in the CMAJ. Full article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.151437

The Canadian Task Force on Preventive Health Care (CTFPHC) has updated its recommendations on screening for lung cancer. In contrast to its previous guidance, the task force now recommends using low-dose CT to screen adults between 55 and 74 years of age who are at high risk for lung cancer on an annual basis for three consecutive years. The change in recommendation is based on a systematic review incorporating new evidence. In this interview podcast, Dr. Gabriela Lewin explains the new recommendations. Dr. Lewin is a member of the CTFPHC and chair of the Lung Cancer Working Group. She is also a family physician in Kemptville, Ontario, and assistant professor in the Department of Family Medicine at University of Ottawa. Full guideline (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.151421

Who should be screened for colorectal cancer? How often? What screening method should be used? Dr. Maria Bacchus, internist at Foothills Hospital in Calgary and Associate Professor in the Department of Medicine at the University of Calgary, explains in this podcast. Dr. Bacchus is one of the authors of this 2016 Canadian Task Force colorectal cancer screening guideline published in the CMAJ. Full guideline (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.151125

Interview with Dr. Kevin Pottie, Associate Professor of Family Medicine, and Epidemiology & Community Medicine at the University of Ottawa. Dr. Pottie is also Principal Scientist at the C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute at the University of Ottawa. As people age, changes to the structure and the function of the brain may result in cognitive decline. These changes, however, do not equally affect all cognitive domains or all people. Should we screen our asymptomatic patients for cognitive impairment? In this evidence-based guideline, the Canadian Task Force on Preventive Health Care recommends that we don’t. Dr. Pottie explains in this podcast. Full guideline (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.141165

The Empire Club of Canada Presents: 2015 Women Who Lead Panel featuring Andrea Stairs, Ilse Treurnicht and Shelley Martin In Conversation With Amber Kanwar As eBay Canada's managing director, Andrea Stairs leads the Canadian strategy and operations of one of the world's largest online marketplaces and Canada's second largest e commerce business. In this role, Andrea is responsible for cultivating eBay's community of Canadian users, from individual consumers to established brands and retailers, and for overseeing all of eBay's Canadian functions, including product management, business development, and public and government relations. Andrea was most recently head of marketing for eBay Canada, managing the brand's marketing strategy and execution. She was also instrumental in launching eBay's French Canadian website and in leading the eBay Motors team in Canada. After receiving a BA from McGill University, Andrea obtained LLB and MBA degrees from the University of Toronto. Andrea sits on executive committee of the board of directors of the Information Technology Association of Canada, ITAC. A native of Montreal, Andrea now lives in Toronto with her husband and young son and daughter. Ilse Treurnicht is the CEO of MaRS Discovery District, a leading innovation centre located in Toronto. She oversees both the development and operations of the MaRS Centre and its broad suite of entrepreneurship and innovation programs. Ilse joined MaRS in early Primaxis Technology Ventures, a startup stage venture capital fund focused on the advanced technologies sector. Prior to Primaxis, she was an entrepreneur with senior management roles in a number of emerging technology companies. Ilse is an active member of Canada's innovation community. She served as Chair of the Canadian Task Force on Social Finance in 2010, and is a member of the Science, Technology and Innovation Council, STIC. Ilse holds a DPhil in chemistry from Oxford University, which she attended as a Rhodes scholar. Shelley Martin is President and CEO of Nestlé Canada Inc., a leading company that produces some of the world's most recognized and trusted foods and beverages. In this role, Shelley has executive responsibility for Nestlé in Canada which includes the following divisions: Beverages, Confectionery, Frozen Meals and Pizza, Ice Cream, Nestlé Professional, Nestlé Purina PetCare, Nestlé Waters, Nestlé Health Science and Nestlé Nutrition. Nestlé in Canada businesses employ approximately 3,600 people in 23 facilities, including manufacturing sites, sales offices and distribution centres nationally. Shelley joined Nestlé Canada in March 1990 working on the PetCare Business in Marketing and in 1997, was promoted to Vice President of Confectionery. Shelley actively participates in industry initiatives and is currently the Vice Chair on the Board of Directors for Food and Consumer Products Canada, FCPC. She serves on the Board of the Grocery Innovation Foundation which has raised over $75 million to provide a better life for challenged... Moderator: Amber Kanwar, Anchor and Reporter at Business News Network Panelists: Andrea Stairs, Managing Director, eBay Canada Ilse Treurnicht, CEO of MaRS Discovery District Shelley Martin, President and CEO, Nestlé Canada Inc *The content presented is free of charge but please note that the Empire Club of Canada retains copyright. Neither the speeches themselves nor any part of their content may be used for any purpose other than personal interest or research without the explicit permission of the Empire Club of Canada.* *Views and Opinions Expressed Disclaimer: The views and opinions expressed by the speakers or panelists are those of the speakers or panelists and do not necessarily reflect or represent the official views and opinions, policy or position held by The Empire Club of Canada.*

Dr. Diane Kelsall, deputy editor, interviews Dr. Patricia Parkin, pediatrician at the Hospital for Sick Children, professor with the University of Toronto Faculty of Medicine. CMAJ recently published new recommendations from the Canadian Task Force on Preventive Health Care, where Dr. Parkin is chair of the child obesity working group. The Task Force recommends structured behavioural interventions for obese and overweight children, but not medications or surgery. There is little evidence showing long-term effectiveness of interventions for obesity prevention. Full guidelines (FREE): http://www.cmaj.ca/content/early/2015/03/30/cmaj.141285

Interview with Paula Brauer, head of the adult obesity working group at the Canadian Task Force on Preventive Health Care. This latest guideline from the Task Force, published in CMAJ, focuses on the growing epidemic of obesity in adults, recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. Full guideline: http://www.cmaj.ca/content/187/3/184